Literature DB >> 20052747

Deferasirox treatment may be associated with reversible renal Fanconi syndrome.

Ehud Even-Or, Rachel Becker-Cohen, Hagit Miskin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20052747     DOI： 10.1002/ajh.21588

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  7 in total

1.  Renal Fanconi syndrome secondary to deferasirox: where there is smoke there is fire.

Authors:  Michel Baum
Journal:  J Pediatr Hematol Oncol       Date:  2010-10       Impact factor: 1.289

Review 2.  Deferasirox nephrotoxicity-the knowns and unknowns.

Authors:  Juan Daniel Díaz-García; Angel Gallegos-Villalobos; Liliana Gonzalez-Espinoza; Maria D Sanchez-Niño; Jesus Villarrubia; Alberto Ortiz
Journal:  Nat Rev Nephrol       Date:  2014-07-22       Impact factor: 28.314

3.  Deferasirox-induced renal impairment in children: an increasing concern for pediatricians.

Authors:  Laurence Dubourg; Céline Laurain; Bruno Ranchin; Corinne Pondarré; Aoumeur Hadj-Aïssa; Dominique Sigaudo-Roussel; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2012-04-24       Impact factor: 3.714

4.  Early Kidney Damage Markers after Deferasirox Treatment in Patients with Thalassemia Major: A Case-Control Study.

Authors:  Hamidreza Badeli; Adel Baghersalimi; Sajjad Eslami; Farshid Saadat; Afagh Hassanzadeh Rad; Rokhsar Basavand; Soghra Rafiei Papkiadeh; Bahram Darbandi; Wesam Kooti; Ilaria Peluso
Journal:  Oxid Med Cell Longev       Date:  2019-04-21       Impact factor: 6.543

5.  Acute kidney injury due to thin basement membrane disease mimicking Deferasirox nephrotoxicity: a case report.

Authors:  Keiko Oda; Kan Katayama; Akiko Tanoue; Tomohiro Murata; Yumi Hirota; Shoko Mizoguchi; Yosuke Hirabayashi; Takayasu Ito; Eiji Ishikawa; Kaoru Dohi; Masaaki Ito
Journal:  BMC Nephrol       Date:  2018-12-17       Impact factor: 2.388

6.  Cost-utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a UK perspective.

Authors:  Anthony Bentley; Samantha Gillard; Michael Spino; John Connelly; Fernando Tricta
Journal:  Pharmacoeconomics       Date:  2013-09       Impact factor: 4.981

Review 7.  Kidney Tubular Damage Secondary to Deferasirox: Systematic Literature Review.

Authors:  Martin Scoglio; Maria Domenica Cappellini; Emanuela D'Angelo; Mario G Bianchetti; Sebastiano A G Lava; Carlo Agostoni; Gregorio P Milani
Journal:  Children (Basel)       Date:  2021-12-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.